Lifting the burden of schistosomiasis - Defining elements of infection-associated disease and the benefits of antiparasite treatment

Journal of Infectious Diseases

Volumn 196, Issue 5, 2007, Pages 653-655

  King, Charles H ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANEMIA; HEMATURIA; HUMAN; INFECTION CONTROL; NOTE; PRIORITY JOURNAL; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

BURKINA FASO; CHILD; HUMANS; POVERTY; SCHISTOSOMIASIS; SCHISTOSOMICIDES;

EID: 34548068015     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/520522     Document Type: Note

References (16)

1. Gryseels B. The relevance of schistosomiasis for public health. Trop Med Parasitol 1989; 40:134-42.
2. Ross AG, Bartley PB, Sleigh AC, et al. Schistosomiasis. N Engl J Med 2002; 346:1212-20.
3. Koukounari A, Gabrielli AF, Touré S, et al. Schistosoma haematobium infection and morbidity before and after large-scale administration of praziquantel in Burkina Faso. J Infect Dis 2007; 196:659-69 (in this issue).
4. Leenstra T, Acosta LP, Langdon GC, et al. Schistosomiasis japonica, anemia, and iron status in children, adolescents, and young adults in Leyte, Philippines 1. Am J Clin Nutr 2006; 83:371-9.
5. King CH, Dickman K, Tisch DJ. Reassessment of the cost of chronic helminthic infection: a meta-analysis of disability-related outcomesin endemic schistosomiasis. Lancet 2005; 365:1561-9.
6. King CH. Epidemiology of schistosomiasis: determinants of transmission of infection. In: Mahmoud AAF, ed. Schistosomiasis. Tropical medicine: science and practice, vol. 3. London: Imperial College Press, 2001:115-32.
7. Chen MG, Mott KE. Progress in assessment of morbidity due to Schistosoma haematobium infection. Trop Dis Bull 1989; 86:R1-36.
8. Sachs JD. The end of poverty. New York: Penguin, 2005.
9. Warren KS. Selective primary health care: strategies for control of disease in the developing world. I. Schistosomiasis. Rev Infect Dis 1982; 4:715-26.
10. Jamison DT, Breman JG, Measham AR, et al. Disease control priorities in developing countries, 2nd ed. New York: Oxford University Press, 2006.
11. King CH, Sturrock RF, Kariuki HC, Hamburger J. Transmission control for schistosomiasis - why it matters now. Trends Parasitol 2006; 22:575-82.
12. Wilson RA, van Dam GJ, Kariuki TM, Farah IO, Deelder AM, Coulson PS. The detection limits for estimates of infection intensity in schistosomiasis mansoni established by a study in non-human primates. Int J Parasitol 2006; 36:1241-4.
13. Friedman JF, Kanzaria HK, McGarvey ST. Human schistosomiasis and anemia: the relationship and potential mechanisms. Trends Parasitol 2005; 21:386-92.
14. Warren KS, Mahmoud AAF, Muruka JF, Whittaker LR, Ouma JH, Arap Siongok TK. Schistosomiasis haematobia in Coast Province, Kenya: relationship between egg output and morbidity. Am J Trop Med Hygiene 1979; 28:864-70.
15. Wamachi AN, Mayadev JS, Mungai PL, et al. Increased ratio of tumor necrosis factor-α to interleukin-10 production is associated with Schistosoma haematobium-induced urinary-tract morbidity. J Infect Dis 2004; 190:2020-30.
16. Guyatt H. Do intestinal nematodes affect productivity in adulthood? Parasitol Today 2000; 16:153-8.